Bone Marrow Transplant
24
4
6
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
1 terminated out of 24 trials
93.8%
+7.2% vs benchmark
13%
3 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (24)
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
Shingrix In Recipients of Allogeneic Transplants
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
Activity Levels in Bone Marrow Transplant Patients
Spanish BMT4me Usability & Acceptability
Cardiovascular Risk in Children With Chronic Conditions Study
Mosaic Trial for Stem Cell Transplant Recipients
Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients
Effects of Digital Stories Intervention on Psychosocial Well-being
Geriatric Communication Skills Training Program for Oncology Clinicians
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
Screening for Subjects to Participate in Studies of Blood Disorders
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
BMT Online Wellness Study
Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
Perspectives on Bone Marrow Donors Who Donate for Their Parent